Mannich Base PIP-199 Is a Chemically Unstable Pan-Assay Interference Compound.

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• PIP-199 is the sole reported small-molecule inhibitor targeting the Fanconi anemia complementation group M-RecQ-mediated genome instability protein (FANCM-RMI) interaction.
• This FANCM-RMI interaction is crucial for regulating genome instability in Fanconi anemia and Bloom's syndrome.
• Indole-derived Mannich base analogues, including PIP-199, have been utilized as research tools in various biological investigations.

Purpose of the Study:

• To report the synthesis of PIP-199 and its analogues.
• To evaluate the stability and inhibitory activity of PIP-199 and related compounds against FANCM-RMI.
• To determine the reliability of PIP-199 as a tool compound in biological studies.

Main Methods:

• Chemical synthesis of PIP-199 and analogues.
• Assessment of compound stability in aqueous buffers and organic solvents.
• Biophysical assays (binding and competitive) to test FANCM-RMI inhibition.

Main Results:

• PIP-199 demonstrated immediate decomposition in common aqueous buffers and some organic solvents.
• Neither PIP-199 nor its more stable analogues exhibited measurable activity in FANCM-RMI binding assays.
• Apparent cellular activity of PIP-199 was attributed to nonspecific toxicity from its decomposition products.

Conclusions:

• PIP-199 is not an effective tool compound due to its instability and lack of specific FANCM-RMI inhibitory activity.
• The observed cellular effects of PIP-199 are likely due to nonspecific toxicity of its breakdown products.
• Mannich base compounds with this scaffold may constitute a new class of pan-assay interference compounds (PAINS) requiring rigorous stability assessment.